l-Ornithine-l-aspartate in the management of hepatic encephalopathy: A meta-analysis

Background and Aim: Hepatic encephalopathy continues to be a major clinical problem and the current decade has not witnessed major therapeutic breakthroughs in this area. l‐ornithine‐l‐aspartate (LOLA) is not frequently used as there are still some reservations about its benefits. The present study...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of gastroenterology and hepatology 2009-01, Vol.24 (1), p.9-14
Hauptverfasser:	Jiang, Qian, Jiang, Xue-Hua, Zheng, Ming-Hua, Chen, Yong-Ping
Format:	Artikel
Sprache:	eng
Schlagworte:	Biological and medical sciences Dipeptides - adverse effects Dipeptides - therapeutic use Gastroenterology. Liver. Pancreas. Abdomen hepatic encephalopathy Hepatic Encephalopathy - drug therapy Humans l-ornithine-l-aspartate Liver. Biliary tract. Portal circulation. Exocrine pancreas Medical sciences meta-analysis Other diseases. Semiology Patient Selection randomized controlled trial Randomized Controlled Trials as Topic Severity of Illness Index treatment Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!